Improving access to prenatal care in rural Côte d'Ivoire
Official title: Supply and Demand-Side Interventions to Improve Uptake of Antenatal Care Services: a Randomized Controlled Trial in Rural Côte d'Ivoire
Run by Swiss Tropical & Public Health Institute · NCT07341581 · Data updated 2026-11-12
This project will test whether short information videos, partner financial-planning sessions, and vouchers help pregnant women in rural Côte d'Ivoire attend recommended antenatal care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years and up |
| Sex | Women only |
| Enrollment | 1290 (estimated) |
| Sponsor | Swiss Tropical & Public Health Institute Academic / other |
| Locations | 1 site (Taabo) |
| Status | Recruiting |
| Started | January 16, 2026 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | January 22, 2026 |
| Trial ID | NCT07341581 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women aged 15 or older with estimated gestational age under six completed months who live in the Taabo Health & Demographic Surveillance System area, and their male partners aged 15 or older who are married to or the main romantic partner of an enrolled woman, are ideal candidates.
✕Probably not a fit
Women beyond six months gestation, those already attending all recommended ANC visits, or people living outside the Taabo surveillance area are unlikely to benefit from these specific interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The investigators will run a randomized controlled experiment in Taabo, Côte d'Ivoire, testing supply- and demand-side interventions to increase uptake of recommended antenatal care. Pregnant women under six months gestation will be randomized to receive an informational video, a joint financial-planning session with their male partner, vouchers to reduce costs, combinations of these, or standard care. Primary outcomes include attendance at recommended ANC visits and receipt of recommended services, measured through facility records and household follow-up. The trial focuses on practical, low-cost interventions that could be scaled if effective.
Why it matters
Potential benefit: If successful, the interventions could increase timely antenatal visits and reduce financial barriers to receiving recommended care, potentially improving maternal and newborn outcomes.
How similar studies have gone: Vouchers and informational campaigns have increased antenatal visit uptake in other low- and middle-income settings, but combining partner-focused financial planning with vouchers is less well-studied and evidence is mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria for pregnant women: * Currently pregnant * Aged 15 years or older * Live in the area served by the Taabo Health \& Demographic Surveillance System * Estimated gestational age of less than 6 completed months of pregnancy Inclusion criteria for male partners: * Aged 15 and older * Married to or currently the main romantic partner of a woman who is enrolled in the study
Where it's running
-
Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
Taabo, Côte d’Ivoire Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Point-of-care newborn SCD screening and early care in Côte d'Ivoire
This trial tests whether using a Gazelle-Multispectral point-of-care test at birth plus early, comprehensive SCD care can reduce illnesses and deaths for babies with SCD in the first years of life.
-
Arpraziquantel in children 6–7 years old with Opisthorchis viverrini infection
This study tests higher and higher doses of arpraziquantel in 6–7 year-olds who are infected to see if more of them are cured and to check safety and acceptability.
-
Switching to sacubitril-valsartan in heart failure with reduced ejection fraction in rural Tanzania
This study tests whether swapping ACE inhibitors or ARBs for sacubitril-valsartan improves health status in adults with heart failure and reduced ejection fraction in rural Tanzania.
-
Using arpraziquantel to treat schistosomiasis in preschool-aged children
This study is testing how well different ways of giving a new child-friendly medicine for schistosomiasis work for preschool-aged kids in Côte d'Ivoire, Kenya, and Uganda.
-
How menstrual pads, tampons, and cups affect vaginal health
We will test whether using pads, tampons, or menstrual cups for two menstrual cycles each changes the types and amounts of vaginal bacteria in people who menstruate aged 18–35 in Peru, Cameroon, and Switzerland.
-
Understanding chronic kidney disease in Sub-Saharan Africa
This study is trying to understand how common chronic kidney disease is in Sub-Saharan Africa and what factors might be causing it by looking at the health and lifestyle of adults in the Bagamoyo district.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.